Clinical Trial Update: COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing a COX-2 inhibitor, a glucocorticoid, and their combination for anterior cruciate ligament rupture has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Rupture

Drugs mentioned

• COX-2 inhibitor (COX-2 inhibitor)
• Glucocorticoid (glucocorticoid)

Snippet

Sponsor: Asker & Baerum Hospital | Conditions: Rupture of Anterior Cruciate Ligament | Phase 4 | Status: COMPLETED